Review



seca i trial  (Seca)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 86
      Buy from Supplier

    Structured Review

    Seca seca i trial
    Seca I Trial, supplied by Seca, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/seca i trial/product/Seca
    Average 86 stars, based on 1 article reviews
    seca i trial - by Bioz Stars, 2026-05
    86/100 stars

    Images



    Similar Products

    seca i trial  (Seca)
    86
    Seca seca i trial
    Seca I Trial, supplied by Seca, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/seca i trial/product/Seca
    Average 86 stars, based on 1 article reviews
    seca i trial - by Bioz Stars, 2026-05
    86/100 stars
    		  Buy from Supplier
    seca-i trial  (Seca)
    90
    Seca seca-i trial
    Summary of existing studies of liver transplantation for colorectal cancer with liver metastases.
    Seca I Trial, supplied by Seca, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/seca-i trial/product/Seca
    Average 90 stars, based on 1 article reviews
    seca-i trial - by Bioz Stars, 2026-05
    90/100 stars
    		  Buy from Supplier
    secondary cancer (seca) i trial  (Seca)
    90
    Seca secondary cancer (seca) i trial
    Summary of existing studies of liver transplantation for colorectal cancer with liver metastases.
    Secondary Cancer (Seca) I Trial, supplied by Seca, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/secondary cancer (seca) i trial/product/Seca
    Average 90 stars, based on 1 article reviews
    secondary cancer (seca) i trial - by Bioz Stars, 2026-05
    90/100 stars
    		  Buy from Supplier
    seca-i trials  (Seca)
    90
    Seca seca-i trials
    Summary of existing studies of liver transplantation for colorectal cancer with liver metastases.
    Seca I Trials, supplied by Seca, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/seca-i trials/product/Seca
    Average 90 stars, based on 1 article reviews
    seca-i trials - by Bioz Stars, 2026-05
    90/100 stars
    		  Buy from Supplier
    lt (seca-i trial)  (Seca)
    90
    Seca lt (seca-i trial)
    Summary of existing studies of liver transplantation for colorectal cancer with liver metastases.
    Lt (Seca I Trial), supplied by Seca, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/lt (seca-i trial)/product/Seca
    Average 90 stars, based on 1 article reviews
    lt (seca-i trial) - by Bioz Stars, 2026-05
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    Summary of existing studies of liver transplantation for colorectal cancer with liver metastases.

    Journal: The Oncologist

    Article Title: Liver transplantation for colorectal cancer with liver metastases

    doi: 10.1093/oncolo/oyae367

    Figure Lengend Snippet: Summary of existing studies of liver transplantation for colorectal cancer with liver metastases.

    Article Snippet: Hagness et al. 2013 SECA-I trial , Norway , 2006–2011 , n = 21 , - Single-arm, prospective - Pts followed with CT CAP every 3-6 months for 5 years , - Resected primary - Minimum 6 weeks of CTX preceding LT - Lack of extrahepatic mets confirmed by CT and ex lap , - Extrahepatic metastases - Other malignancy - Weight loss > 10% , - OS rate at 1, 3, 5 years: 95%, 68%, 60% - DFS rate at 1 year: 35% - CEA > 80 μg/L and largest tumor > 5.5 cm associated with shorter OS.

    Techniques: Transplantation Assay, Control, Comparison